Sun Pharma /taro recalls Lidocaine Ointment USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
- Products
-
- Lidocaine Ointment USP
- Company
- Sun Pharma /taro
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 65,328 50g jars
- About this recall
- Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5